WOBURN, Mass., Jan. 15, 2019 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change […]
SOUTH SAN FRANCISCO, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) — VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new […]